Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant fusion protein consisting of human coagulation factor VIII attached to the Fc domain of human IgG1

EU orphan designation number: EU/3/10/783   
Active ingredient: Recombinant fusion protein consisting of human coagulation factor VIII attached to the Fc domain of human IgG1
Indication: Treatment of haemophilia A
Sponsor: Biogen Idec Limited
Innovation House, 70 Norden Road, Maidenhead, Berkshire SL6 4AY, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/09/2010 Centralised Orphan - Designation EMA/OD/030/10 (2010)6650 of 20/09/2010